MINNEAPOLIS, Sept. 29, 2015 /PRNewswire/ -- DaVita Clinical
Research (DCR), a specialty contract research organization with
services spanning a broad spectrum of drug and device development,
is celebrating 30 years of accomplishments and milestones in
helping shape the future of medicine.
DCR began in 1985 as a pharmacology unit within an academic
hospital, conducting drug clearance and pharmacokinetic studies.
With a history of renal expertise, DCR has been involved in the
development of every end-stage renal disease drug that has received
approval from the United States Federal Drug Administration in the
last 15 years.
As a part of a large health care provider DCR strives to make a
significant impact on patient care. DCR has completed more than 500
clinical trials and produced over 600 publications since 2006.
"Our team is proud to combine our health care experience and
knowledge of drug development to provide insights to our partners,"
said Amy Young, vice president and
general manager for DCR. "This expertise is becoming even more
important as the landscape of health care continues to evolve."
The company has grown to offer a suite of drug development
services including multi-site full service phase I clinics, late
phase trial services in the United
States and Europe and
health economics and data research capabilities.
Expanded capabilities now cover multiple therapeutic areas and
include early and late phase clinical trials, health economics and
outcomes research, real-world health care data and medical
communications services.
Key milestones during the last 30 years include:
1985:
- Established as Hennepin County Drug Evaluation Unit in
Minneapolis
1997:
- The Drug Evaluation Unit was acquired by Total Renal Care and
became Total Renal Research Inc.
2000:
- Total Renal Care adopted DaVita as its new name and the
research unit changed its name to DaVita Clinical Research
- Added late-stage trial capabilities
2005:
- DaVita's acquisition of Gambro doubles research footprint
2007:
- Added health economics, medical communications and real-world
evidence services
2010:
- Added early clinical and clinical development recruitment
capabilities
2012:
- Became full service and multi-center with the addition of new
early clinical research site in Denver and the addition of integrated data
management services
- DaVita acquires HealthCare Partners, bringing additional late
stage clinical trial health outcomes research and data
capabilities
2015:
- Hosted first-ever Investigator Appreciation Day
- Announced European clinical trial capabilities
Examples of conditions DCR studies include diabetes,
hypertension, healthy men and women, kidney disease, liver disease
and congestive heart failure. DCR's leadership team comprises
physicians and operators who offer unique perspectives that come
from being a provider-based clinical research organization.
For more information or to learn how to enroll in a study,
please visit iSupportResearch.com. To sponsor a study or register
as a clinical investigator, visit DaVitaClinicalResearch.com.
DaVita Clinical Research and DCR are registered trademarks of
DaVita Healthcare Partners Inc.
About DaVita Clinical Research (DCR)
DaVita Clinical Research (DCR), a wholly owned subsidiary
of DaVita HealthCare Partners Inc. (NYSE: DVA), uses its
extensive, applied database and real-world health care experience
to assist pharmaceutical and medical device companies in the
design, recruitment and completion of
retrospective, prospective and pragmatic
clinical trials. DCR's scientific and clinical expertise
spans the lifecycle of product development with more than 175
client companies. DCR's early clinical research unit (Phase
I-IIa) and late phase clinical research (Phase IIb through
post-marketing) network of physicians and investigative sites,
real-world health care data, health economics and outcomes
research, and medical communications are focused on providing
world-class research in both complex/specialty populations and
therapeutic areas, and especially in CKD and ESRD populations. To
learn more about DCR,
visit www.davitaclinicalresearch.com.
Media Contact:
Bianca Violante
Office: (303) 876-6614
Mobile: (443) 417-6044
Bianca.Violante@DaVita.com
Logo -
http://photos.prnewswire.com/prnh/20140212/DC63568LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/30-years-of-clinical-research-milestones-300150256.html
SOURCE DaVita Clinical Research